Advanced search
Publication Cover
Cancer Management and Research Volume 11, 2019 - Issue
Submit an article Journal homepage
56
Views
13
CrossRef citations to date
0
Altmetric
Original Research

LncRNA PCAT-1 Promoted ESCC Progression via Regulating ANXA10 Expression by Sponging miR-508-3p

Bao ZangDepartment of Thoracic Surgery, The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an 223300, Jiangsu, People’s Republic of ChinaCorrespondence[email protected]
,
Jianqiang ZhaoDepartment of Thoracic Surgery, The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an 223300, Jiangsu, People’s Republic of China
&
Chen ChenDepartment of Thoracic Surgery, The Affiliated Huai’an No.1 People’s Hospital of Nanjing Medical University, Huai’an 223300, Jiangsu, People’s Republic of China
Pages 10841-10849 | Published online: 30 Dec 2019

References

  • Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015. CA Cancer J Clin. 2016;66(2 ):115–132. doi:10.3322/caac.2133826808342
  • Enzinger PC, Mayer RJ. Esophageal cancer. N Engl J Med. 2003;349(23 ):2241–2252. doi:10.1056/NEJMra03501014657432
  • Wu SG, Zhang WW, He ZY, Sun JY, Chen YX, Guo L. Sites of metastasis and overall survival in esophageal cancer: a population-based study. Cancer Manag Res. 2017;9:781–788. doi:10.2147/CMAR.S15035029255373
  • Kung JT, Colognori D, Lee JT. Long noncoding RNAs: past, present, and future. Genetics. 2013;193(3 ):651–669. doi:10.1534/genetics.112.14670423463798
  • Su M, Xiao Y, Ma J, et al. Long non-coding RNAs in esophageal cancer: molecular mechanisms, functions, and potential applications. J Hematol Oncol. 2018;11(1 ):118. doi:10.1186/s13045-018-0663-830223861
  • Liu B, Pan CF, Yao GL, Wei K, Xia Y, Chen YJ. The long non-coding RNA AK001796 contributes to tumor growth via regulating expression of p53 in esophageal squamous cell carcinoma. Cancer Cell Int. 2018;18:38. doi:10.1186/s12935-018-0537-829568233
  • Prensner JR, Iyer MK, Balbin OA, et al. Transcriptome sequencing across a prostate cancer cohort identifies PCAT-1, an unannotated lincRNA implicated in disease progression. Nat Biotechnol. 2011;29(8 ):742–749. doi:10.1038/nbt.191421804560
  • Liu L, Liu Y, Zhuang C, et al. Inducing cell growth arrest and apoptosis by silencing long non-coding RNA PCAT-1 in human bladder cancer. Tumour Biol. 2015;36(10 ):7685–7689. doi:10.1007/s13277-015-3490-325934337
  • Yan TH, Yang H, Jiang JH, et al. Prognostic significance of long non-coding RNA PCAT-1 expression in human hepatocellular carcinoma. Int J Clin Exp Pathol. 2015;8(4 ):4126–4131.26097602
  • Zhao B, Hou X, Zhan H. Long non-coding RNA PCAT-1 over-expression promotes proliferation and metastasis in non-small cell lung cancer cells. Int J Clin Exp Med. 2015;8(10 ):18482–18487.26770456
  • Qiao L, Liu X, Tang Y, Zhao Z, Zhang J, Feng Y. Down regulation of the long non-coding RNA PCAT-1 induced growth arrest and apoptosis of colorectal cancer cells. Life Sci. 2017;188:37–44. doi:10.1016/j.lfs.2017.08.02428855110
  • Shi WH, Wu QQ, Li SQ, et al. Upregulation of the long noncoding RNA PCAT-1 correlates with advanced clinical stage and poor prognosis in esophageal squamous carcinoma. Tumour Biol. 2015;36(4 ):2501–2507. doi:10.1007/s13277-014-2863-325731728
  • Yang Z, Zhao S, Zhou X, Zhao H, Jiang X. PCAT-1: a pivotal oncogenic long non-coding RNA in human cancers. Biomed Pharmacother. 2019;110:493–499. doi:10.1016/j.biopha.2018.12.01430530229
  • Zhang X, Zhang Y, Mao Y, Ma X. The lncRNA PCAT1 is correlated with poor prognosis and promotes cell proliferation, invasion, migration and EMT in osteosarcoma. Onco Targets Ther. 2018;11:629–638. doi:10.2147/OTT.S15206329430187
  • Xu W, Chang J, Du X, Hou J. Long non-coding RNA PCAT-1 contributes to tumorigenesis by regulating FSCN1 via miR-145-5p in prostate cancer. Biomed Pharmacother. 2017;95:1112–1118. doi:10.1016/j.biopha.2017.09.01928922730
  • Zhang F, Wan M, Xu Y, et al. Long noncoding RNA PCAT1 regulates extrahepatic cholangiocarcinoma progression via the Wnt/beta-catenin-signaling pathway. Biomed Pharmacother. 2017;94:55–62. doi:10.1016/j.biopha.2017.07.02528753454
  • Zhang D, Cao J, Zhong Q, et al. Long noncoding RNA PCAT-1 promotes invasion and metastasis via the miR-129-5p-HMGB1 signaling pathway in hepatocellular carcinoma. Biomed Pharmacother. 2017;95:1187–1193. doi:10.1016/j.biopha.2017.09.04528931210
  • Liu SH, Lin CY, Peng SY, et al. Down-regulation of annexin A10 in hepatocellular carcinoma is associated with vascular invasion, early recurrence, and poor prognosis in synergy with p53 mutation. Am J Pathol. 2002;160(5 ):1831–1837. doi:10.1016/S0002-9440(10)61129-712000734
  • Munksgaard PP, Mansilla F, Brems Eskildsen AS, et al. Low ANXA10 expression is associated with disease aggressiveness in bladder cancer. Br J Cancer. 2011;105(9 ):1379–1387. doi:10.1038/bjc.2011.40421979422
  • Hu T, Li Z, Gao CY, Cho CH. Mechanisms of drug resistance in colon cancer and its therapeutic strategies. World J Gastroenterol. 2016;22(30 ):6876–6889. doi:10.3748/wjg.v22.i30.687627570424
  • Hu T, To KK, Wang L, et al. Reversal of P-glycoprotein (P-gp) mediated multidrug resistance in colon cancer cells by cryptotanshinone and dihydrotanshinone of Salvia miltiorrhiza. Phytomedicine. 2014;21(11 ):1264–1272. doi:10.1016/j.phymed.2014.06.01325172788
  • Hu T, Wang L, Zhang L, et al. Sensitivity of apoptosis-resistant colon cancer cells to tanshinones is mediated by autophagic cell death and p53-independent cytotoxicity. Phytomedicine. 2015;22(5 ):536–544. doi:10.1016/j.phymed.2015.03.01025981919

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.